Regeneron Pharmaceuticals
2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation NCT06299098 | Trevogrumab | Phase 2 | Active not recruiting | Regeneron Pharmaceuticals | 1,005 | Jun 16, 2026 | Sep 1, 2026 |
| Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia NCT01963598 | Trevogrumab | Phase 2 | Completed | Regeneron Pharmaceuticals | 253 | Jan 2015 | Mar 28, 2016 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
